共 89 条
[1]
Carmina E(1999)Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women J Clin Endocrinol Metab 84 1897-1899
[2]
Lobo RA(2000)A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain J Clin Endocrinol Metab 85 2434-2438
[3]
Asuncion M(2004)The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2745-2749
[4]
Calvo RM(1995)Polycystic ovary syndrome N Engl J Med 333 85361-800
[5]
San Millan JL(1997)Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 774-114
[6]
Sancho J(2002)Polycystic ovary syndrome. Long term sequelae and management Minerva Ginecol 54 97-145
[7]
Avila S(2006)Obesity and polycystic ovary syndrome Clin Endocrinol 65 137-413
[8]
Escobar Morreale HF(2006)Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome Clin Chem 52 405-625
[9]
Azziz R(2006)Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome Eur J Clin Invest 36 621-6975
[10]
Woods KS(2006)A genetic variant at the fatty acid-binding protein ap2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease PNAS 103 6970-47